Altre lingue Peak Bio, Inc.

Azioni

PKBO

US70470P1084

Mercato chiuso - OTC Markets Altri mercati azionari 16:39:07 25/06/2024			Variaz. 5gg	Var. 1 gen.
0,0096 ^USD	+11,63%		+11,63%	-94,88%

25/06	Peak Bio, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI
2023	Peak Bio, Inc. nomina Michael Friedman nel Consiglio di Amministrazione e membro del Comitato di Revisione e del Comitato per le Remunerazioni	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	25/06
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders	06/06
Peak Bio, Inc. announced that it has received $1.3245 million in funding	28/05
Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc..	05/03
Peak Bio, Inc. announced that it has received $2.238 million in funding	16/02
Peak Bio, Inc. Receives Loan in the Principal Amount of $750,000	29/01
Peak Bio, Inc. announced that it has received $0.075 million in funding	23/01
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing	04/01
Peak Bio, Inc. announced a financing transaction	18/12
Peak Bio : Private Placement - Form 8-K	02/11
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing	19/09/23
Peak Bio, Inc. Announces Up-listing to OTCQB Market	31/08/23
Peak Bio, Inc. Announces Up-listing to OTCQB Market	31/08/23
Peak Bio, Inc. Appoints Michael Friedman to Board of Directors and Member of Audit Committee and Compensation Committee	31/08/23
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	31/08/23
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	31/08/23
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	29/08/23
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	29/08/23
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital	24/08/23
Peak Bio, Inc. announced that it expects to receive $100 million in funding from White Lion Capital Llc	24/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Peak Bio, Inc.

Azioni

PKBO

US70470P1084

Altre lingue

Filtri